GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » Interest Expense

Qingdao Haier Biomedical Co (SHSE:688139) Interest Expense : ¥-3 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Qingdao Haier Biomedical Co's interest expense for the three months ended in Mar. 2024 was ¥ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Qingdao Haier Biomedical Co's Operating Income for the three months ended in Mar. 2024 was ¥ 145 Mil. Qingdao Haier Biomedical Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -1 Mil. Qingdao Haier Biomedical Co's Interest Coverage for the quarter that ended in Mar. 2024 was 172.56. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Qingdao Haier Biomedical Co Interest Expense Historical Data

The historical data trend for Qingdao Haier Biomedical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Haier Biomedical Co Interest Expense Chart

Qingdao Haier Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial -0.34 -0.08 -2.89 -2.69 -3.51

Qingdao Haier Biomedical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.89 -0.99 -0.97 -0.67 -0.84

Qingdao Haier Biomedical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qingdao Haier Biomedical Co  (SHSE:688139) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Qingdao Haier Biomedical Co's Interest Expense for the three months ended in Mar. 2024 was ¥-1 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥145 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥9 Mil.

Qingdao Haier Biomedical Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*145.469/-0.843
=172.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Qingdao Haier Biomedical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.


Qingdao Haier Biomedical Co (SHSE:688139) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Haier Road, Branding Building, Qingdao, CHN, 266101
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
Executives
Zhang Jiang Tao Core technical personnel
Liu Ji Yuan Core technical personnel
Teng Pei Kun Core technical personnel
Wang Guang Sheng senior management
Gong Yi Director
Huang Yan Li senior management
Chen Hai Tao Senior management, core technical personnel
Liu Zhan Jie Directors, senior managers, core technical personn
Mo Rui Juan senior management
Wang Wen Fu Director

Qingdao Haier Biomedical Co (SHSE:688139) Headlines

No Headlines